CD133 exhibited an increased mRNA content from 0.95 (Min–Max: 0.41–5.21) to 3.57 (Min–Max: 0.04–99.55) in GBM but this failed to reach statistical significance (p = 0.0879). The gene discussed is PROM1; the disease is glioblastoma.